AGIO Market Cap History
Below is a table of the AGIO market cap history going back to 7/24/2013:

Date AGIO Market Cap

Also see: AGIO Shares Outstanding History
and AGIO YTD Return
AGIO Historical Market Cap:
+13.15% CAGR
AGIO Historical Market Cap: +13.15% CAGR

Mouse over chart for data details
7/24/2013 ...10/29/2021
Agios Pharmaceuticals is a biopharmaceutical company focused on improving patients' lives in the field of cellular metabolism and adjacent areas of biology, with the goal of creating molecule medicines in the areas of genetically defined diseases (GDD), hematologic malignancies and solid tumors. Co.'s wholly-owned product, TIBSOVO® (ivosidenib) is an oral targeted inhibitor of the mutated isocitrate dehydrogenase 1 enzyme. TIBSOVO® is for the treatment of adult patients with relapsed or refractory acute myeloid leukemia. The primary product candidate in Co.'s GDD portfolio, mitapivat, is an activator of both wild-type and mutant pyruvate kinase-R for the treatment of hemolytic anemias. We show 34 historical shares outstanding datapoints in our AGIO shares outstanding history coverage, used to compute AGIO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AGIO market cap history over the course of time is important for investors interested in comparing AGIO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AGIO versus a peer is one thing; comparing AGIO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AGIO can fluctuate over the course of history. With this page we aim to empower investors researching AGIO by allowing them to research the AGIO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AGIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Agios Pharmaceuticals (AGIO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AGL Market Cap History
AGLE Market Cap History
AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
AGTI Market Cap History
AHCO Market Cap History
AHPI Market Cap History
AIKI Market Cap History
AIMT Market Cap History
More Healthcare companies »


AGIO Market Cap History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.